Inogen reported $74.93M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.34B 30M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 842M 40.3M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Philips EUR 4.4B 40M Sep/2026
ResMed USD 1.46B 60M Jun/2026
Steris USD 1.59B 88.6M Sep/2026
Stryker USD 6.5B 100M Sep/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
X T L Biopharmaceuticals USD 289K 127K Dec/2024
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026